Clinical Trials Directory

Trials / Conditions / Chronic Hepatitis D

Chronic Hepatitis D

8 registered clinical trials studyying Chronic Hepatitis D — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingPhase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevi
NCT07454837
Mirum Pharmaceuticals, Inc.Phase 2 / Phase 3
Active Not RecruitingTrial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis
NCT06649266
Ribocure Pharmaceuticals ABPhase 2
RecruitingStudy to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
NCT06051045
Karolinska University Hospital—
CompletedIncidence of Viral Hepatitis D Relapses Upon Discontinuation of Bulevirtide in Patients With Chronic Hepatitis
NCT06121427
Center of target therapy—
CompletedBurden of Hepatitis D Virus (HDV) Infection in Italy
NCT05723068
University of Turin, Italy—
UnknownEzetimibe for Patients With Chronic Hepatitis D
NCT03099278
Ziauddin HospitalPhase 2
UnknownPegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
NCT00117533
National Taiwan University HospitalPhase 4
CompletedLamivudine for Chronic Hepatitis B
NCT00001457
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2